197 related articles for article (PubMed ID: 11225756)
1. Type 2 diabetes and atherosclerosis.
Donnelly R; Davis KR
Diabetes Obes Metab; 2000 Mar; 2 Suppl 1():S21-30. PubMed ID: 11225756
[No Abstract] [Full Text] [Related]
2. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
Janka HU; Standl E
Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
[No Abstract] [Full Text] [Related]
3. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Haffner SM
Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
[TBL] [Abstract][Full Text] [Related]
4. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?
Jarrett RJ
Diabetologia; 1984 Feb; 26(2):99-102. PubMed ID: 6370765
[TBL] [Abstract][Full Text] [Related]
5. Post-prandial hyperglycaemia and vascular disease.
Hanefeld M
Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
[No Abstract] [Full Text] [Related]
6. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
Lewis GF; Steiner G
Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
[No Abstract] [Full Text] [Related]
7. Nutrition and diabetes: the role of fat.
Kromhout D; Feskens EJ
Acta Cardiol; 1993; 48(5):444-5. PubMed ID: 8284971
[No Abstract] [Full Text] [Related]
8. Multifactorial aspects of the treatment of the type II diabetic patient.
Colwell JA
Metabolism; 1997 Dec; 46(12 Suppl 1):1-4. PubMed ID: 9439550
[TBL] [Abstract][Full Text] [Related]
9. Heart disease in diabetic patients.
Blendea MC; McFarlane SI; Isenovic ER; Gick G; Sowers JR
Curr Diab Rep; 2003 Jun; 3(3):223-9. PubMed ID: 12762970
[TBL] [Abstract][Full Text] [Related]
10. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
Mazzone T
J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
[No Abstract] [Full Text] [Related]
11. Atherosclerotic vascular disease in middle-aged, insulin-treated, diabetic patients. Association with endogenous insulin secretion capacity.
Rönnemaa T; Laakso M; Puukka P; Kallio V; Pyörälä K
Arteriosclerosis; 1988; 8(3):237-44. PubMed ID: 3285822
[TBL] [Abstract][Full Text] [Related]
12. [Atherosclerosis in diabetes mellitus].
Stange EF
Internist (Berl); 1989 May; 30(5):297-303. PubMed ID: 2661472
[No Abstract] [Full Text] [Related]
13. Diabetes and atherosclerosis.
Stout RW
Biomed Pharmacother; 1993; 47(1):1-2. PubMed ID: 8329659
[TBL] [Abstract][Full Text] [Related]
14. From an excess of fat, diabetics die.
Steiner G
JAMA; 1989 Jul; 262(3):398-9. PubMed ID: 2491411
[No Abstract] [Full Text] [Related]
15. Risk factors of macrovascular disease in diabetes mellitus.
Jarrett RJ
Horm Metab Res Suppl; 1985; 15():1-3. PubMed ID: 3865876
[No Abstract] [Full Text] [Related]
16. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland.
Laakso M; Rönnemaa T; Pyörälä K; Kallio V; Puukka P; Penttilä I
Diabetes Care; 1988 Jun; 11(6):449-63. PubMed ID: 3402300
[TBL] [Abstract][Full Text] [Related]
17. Diabetic vascular disease.
Feingold KR; Siperstein MD
Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
[No Abstract] [Full Text] [Related]
18. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
[No Abstract] [Full Text] [Related]
19. [Microangiopathic complications in type 2 diabetes].
Strojek K; Grzeszczak W
Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533
[TBL] [Abstract][Full Text] [Related]
20. Introduction: Symposium on diabetes, inflammation and cardiovascular disease.
Smith U
J Intern Med; 2007 Aug; 262(2):142-4. PubMed ID: 17645582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
